Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases (GRABM-B)

This study has been completed.
Information provided by (Responsible Party):
Angiochem Inc Identifier:
First received: November 16, 2011
Last updated: July 11, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 11, 2016